Vancouver, Canada
Joined April 2021
- Tweets480
- Following121
- Followers856
- Likes509
Filament Health retweeted
This PR makes us very proud as we have so much respect for Veterans. 🫡
$TRIP $TRUFF news. @redlightholland x @FilamentHealth
newsfilecorp.com/release/304…
Filament Health retweeted
Today, @TheraPsil alongside @SabiMind and @FilamentHealth launched the first wellness-focused & stakeholder-funded psilocybin clinical trial.
Psychedelic research is about to change.
See full release here: therapsil.ca/press-psilwell-…
Filament Health retweeted
.@FilamentHealth has received FDA approval for another clinical trial on its lead drug candidate PEX010.
$FLHLF #psilocybin #Veterans #psychedelics
mugglehead.com/fda-gives-ano…
Today we announced positive data from a phase 2 study of PEX010 in patients with alcohol use disorder. The study found that after 1 dose of #psilocybin, the mean % of heavy drinking days was reduced by more than 50% over the 12-week observation period.
filament.health/news/filamen…
Filament Health retweeted
.@benlightburn @FilamentHealth discusses the company’s approach to psychedelic medicine, the case for natural botanical extracts rather than synthetic compounds, and its lead experimental therapy that targets methamphetamine use disorder.
thebioreport.podbean.com/e/e…
Today we announced the import of Peruvian coca leaf to our Vancouver R&D facility for the development of a botanical drug candidate to treat ADHD.
filament.health/news/filamen…
We're proud to supply our botanical psilocybin drug candidate for this much-needed research into opioid use disorder at @imperialcollege.
A groundbreaking clinical trial will explore the use of psilocybin, the active compound in magic mushrooms, to combat opioid addiction. 🍄
This ‘first in the UK’ study aims to help prevent relapse with the power of psychedelics and psychological support.
imperial.ac.uk/news/257294/i…
Today we announced a major expansion of our IP portfolio, with 12 new patents accepted in Australia, 5 in Canada, & 3 in the US. Filament holds a total of 46 allowed patents relating to the development & delivery of naturally-derived psychedelic APIs.
filament.health/news/filamen…
Today we announced authorization by both @US_FDA & @GovCanHealth of a Phase 2 clinical trial studying PEX010 for methamphetamine use disorder. This is the first ever clinical trial to study the safety & efficacy of botanical #psilocybin for MAUD.
filament.health/news/filamen…
We're pleased to report our Q1 2024 results, including important advancement of our drug development efforts in substance use disorders.
filament.health/news/filamen…
Our CEO @benlightburn will be hosting an #AMA with @ceodotca at 12PM ET tomorrow to discuss our latest news and developments. Submit questions for Ben via: ceo.ca/@ceoca_james
We're pleased to report our 2023 year-end results including $2.1 million in revenue + @GovCanHealth approval of a Filament-sponsored Phase 2 clinical trial studying our botanical psilocybin for opioid use disorder at @UBC.
filament.health/news/filamen…
We're pleased to announce that Michael Messinger has been appointed to our Board of Directors, bringing over 20 years' experience in biotech finance roles.
filament.health/news/filamen…
Filament Health retweeted
Join Robert Sassoon for a fireside chat with @FilamentHealth CEO Ben Lightburn on Thursday, April 4th, at 12:00 pm ET.
#psychedelics #psychedelictherapy #therapeutics
us06web.zoom.us/webinar/regi…
Read about @UCalgary's upcoming study which will examine the effects of our botanical #psilocybin for alcohol use disorder:
Can the power of magic mushrooms overcome the pull of alcohol use disorder? 🍄🍻
An upcoming study based in Canada aims to shed light on the potential for psilocybin’s role in battling the beast that is alcohol addiction. hightimes.com/study/study-ai…
Filament Health retweeted
The @UCalgary is about to start a major study on psilocybin-assisted therapy for the treatment of alcoholism.
British Columbia’s @FilamentHealth will provide magic mushroom extract needed for the research.
$FLHLF #psychedelics #psilocybin
mugglehead.com/alberta-unive…
We're proud to supply our botanical psilocybin for this important research at @UCalgary:
Mushrooms' potential magic in quelling alcohol abuse the focus of U of C researchers #yyc calgaryherald.com/news/local…
Today we announced that we have shipped our botanical psilocybin drug candidate, PEX010, to 4 countries for clinical trials at leading research institutions including @JohnsHopkins.
filament.health/news/filamen…
Could psilocybin offer a solution to the opioid crisis? We take a look in our latest blog post:
filament.health/news/psyched…
Filament Health retweeted
2024 is set to be a watershed year for #Psychedelics.
Alongside an influx of biotech investment in the UK, the industry has seen significant milestones set to accelerate the sector, return confidence & advance #MentalHealth innovations.
Find out more. 👇
psychedelichealth.co.uk/2024…
